BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 392590)

  • 1. Factor VIII physiology and pathology in man.
    Koutts J; Howard MA; Firkin BG
    Prog Hematol; 1979; 11():115-45. PubMed ID: 392590
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factor VIII (anti-hemophilic A factor). Biology, physiology, pathology and genetics].
    Meyer D; Dray L; Allain JP; Larrieu MJ
    Pathol Biol (Paris); 1972; 20(11):607-23. PubMed ID: 4558579
    [No Abstract]   [Full Text] [Related]  

  • 4. Von Willebrand's disease--a common bleeding disorder.
    Lian EC
    Adv Intern Med; 1977; 22():207-28. PubMed ID: 320841
    [No Abstract]   [Full Text] [Related]  

  • 5. Inherited variants of factor-VIII-related protein in von Willebrand's disease.
    Peake IR; Bloom AL; Giddings JC
    N Engl J Med; 1974 Jul; 291(3):113-7. PubMed ID: 4546110
    [No Abstract]   [Full Text] [Related]  

  • 6. Canine von Willebrand's disease.
    Dodds WJ
    J Lab Clin Med; 1970 Nov; 76(5):713-21. PubMed ID: 5312238
    [No Abstract]   [Full Text] [Related]  

  • 7. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 8. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
    Mimaya J; Nagao T; Iizuka A; Yamashita H
    Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH conference. Factor VIII.
    Ann Intern Med; 1977 May; 86(5):598-616. PubMed ID: 300583
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].
    Yoshioka A; Takahashi Y
    Rinsho Byori; 1983 Nov; 31(11):1176-85. PubMed ID: 6423868
    [No Abstract]   [Full Text] [Related]  

  • 12. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII/von Willebrand factor.
    Zimmerman TS; Ruggeri ZM; Fulcher CA
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor VIII-related properties in platelets from patients with von Willebrand's disease.
    Ruggeri ZM; Mannucci PM; Bader R; Barbui T
    J Lab Clin Med; 1978 Jan; 91(1):132-40. PubMed ID: 304081
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Enhanced factor VIII activity in von Willebrand's disease.
    Mannucci PM; Pareti FI; Ruggeri ZM
    N Engl J Med; 1974 May; 290(22):1259. PubMed ID: 4545219
    [No Abstract]   [Full Text] [Related]  

  • 17. [Von-Willebrand-Jürgens syndrome].
    Winckelmann G
    Med Klin; 1973 Jan; 68(2):37-42. PubMed ID: 4567798
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleeding time after aspirin in disorders of intrinsic clotting.
    Kaneshiro MM; Mielke CH; Kasper CK; Rapaport SI
    N Engl J Med; 1969 Nov; 281(19):1039-42. PubMed ID: 5307310
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for the treatment of von Willebrand's disease.
    Sultan Y
    Prog Clin Biol Res; 1981; 72():149-62. PubMed ID: 6801684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.